Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Inas Abuali"'
Autor:
Ilana Schlam, Kelly A. Hirko, Daniela Shveid, Inas Abuali, Sarah Sewaralthahab, Faina Nakhils, Aditi Hazra, Csongor Lengyel, Sara Altuna, Sadaqat Hussain, Fahmi Seid, Sara Jamil, Andrew Odhiambo, Jose Pablo Leone, Otto Metzger, Jame Abraham, Enrique Soto-Perez-de-Celis, Wendy Y. Chen, Caroline Block, Susan Schumer, Jennifer R. Bellon, Carmine Valenza, Giuseppe Curigliano, Sara M. Tolaney, Filipa Lynce, Dario Trapani
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSETrimodal therapy (TMT) is the standard treatment for patients with nonmetastatic inflammatory breast cancer (IBC). TMT consists of neoadjuvant systemic therapy, modified radical mastectomy (MRM), and postmastectomy radiation therapy. Although
Externí odkaz:
https://doaj.org/article/7faf75397c1546b2b6193a10a371cf8b
Publikováno v:
Human Resources for Health, Vol 22, Iss 1, Pp 1-4 (2024)
Abstract Though we have made ample advances in the field of medicine in recent years, our idea of professionalism continues to be based on the standard of how white men dressed in the nineteenth century. Such a standard of professionalism not only pe
Externí odkaz:
https://doaj.org/article/d863fba0f5934245af9d57a4768a8900
Publikováno v:
Clinical Hematology International, Vol 5, Iss 1, Pp 29-37 (2022)
Abstract Health disparities in multiple myeloma (MM) disproportionately affect minorities. Characterization of health disparities encountered by Hispanic Americans with MM is necessary to identify gaps and inform future strategies to eliminate them.
Externí odkaz:
https://doaj.org/article/c9e45bcc1c8e4157b02f65f3ce0fc535
Publikováno v:
Pharmaceuticals, Vol 16, Iss 2, p 233 (2023)
The neoadjuvant use of immune checkpoint inhibitors (ICI) in resectable non-small cell lung cancer (NSCLC) is being increasingly adopted, but questions about the most appropriate applications remain. Although patients with resectable NSCLC are often
Externí odkaz:
https://doaj.org/article/72dd4b1efd0d4600b39a49583753f762
Autor:
Trisha Wise-Draper, Eric Vick, Inas Abuali, Andrew Kelleher, Sarah Ludvigsen, Nathanael Moore, Nicholas Arias, Shuchi Gulati
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/462c00ab25874afaa5bd0ab022ef75c3
Autor:
Trisha Wise-Draper, Eric Vick, Inas Abuali, Andrew Kelleher, Sarah Ludvigsen, Nathanael Moore, Nicholas Arias, Shuchi Gulati
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/93324093cd2e47a5a7b2cf92eee016b8
Publikováno v:
Cancer Cell. 41:1-4
Autor:
Dame Idossa, Ana I. Velazquez, Miki Horiguchi, Julia Alberth, Inas Abuali, Demetria Smith-Graziani, Gilberto de Lima Lopes, Sam Lubner, Narjust Florez
Publikováno v:
JCO Oncology Practice.
PURPOSE Physician workforce diversity can be a driver of institutional excellence, improving innovation and reducing health disparities. However, the current diversity of the hematology/oncology (HO) workforce does not reflect that of the US populati
Autor:
Shruti R Patel, Ivy Riano, Inas Abuali, Angela Ai, Gabriella Geiger, Jacqueline Pimienta, Adriana Ramirez Roggio, Natasha Dhawan, Nazli Dizman, Alexandra Lizette Salinas, Hugo Pomares-Millan, Narjust Florez
Publikováno v:
The Oncologist.
Introduction Women and underrepresented groups in medicine hold few academic leadership positions in the field of hematology/oncology. In this study, we assessed gender and race/ethnicity representation in editorial board positions in hematology/onco
Autor:
Samer Al Hadidi, Inas Abuali
Publikováno v:
Cancer investigation.